Clinical trial
Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)
NCT00153530 · Charite University, Berlin, Germany, Other · Completed
Key facts
| NCT number | NCT00153530 |
|---|---|
| Title | Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL) |
| Official title | Phase IV Study on the Role of Whole Brain Irradiation in Primary CNS Lymphoma (PCNSL) After High-dose Methotrexate |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Collaborators | University Hospital Tuebingen |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Central Nervous System Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | methotrexate, radiotherapy |
| Enrollment | 604 |
| Start date | May 1, 2000 |
| Completion | May 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 24, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: